Laboratórios Atral in Portugal joins humanova Lab Corporation to transform global health

On February 20, a historic milestone was marked for Laboratórios Atral S.A. with the official announcement of its integration into humanova Lab Corporation. This strategic move strengthens the group’s presence across more than 50 international markets, through its nine operations distributed across multiple countries, including Portugal, reinforcing its commitment to improving health worldwide.

humanova operates under an integrated strategy, with a shared vision and culture driven by a common purpose: to enhance the organization’s impact within the pharmaceutical industry.

In front of more than 350 collaborators gathered at Quinta da Grilla, the CEO of Laboratórios Atral, Enrique Gonzalez Jover, highlighted that this step represents not only a corporate integration, but the beginning of a “new dimension” for the project.

As CEO of Laboratórios Atral, he expressed his deep honor in having worked alongside an extraordinary team—individuals defined by talent, commitment, and exceptional human quality—who made this milestone possible.

“This step represents the culmination of years of work and bold decisions. Today, we are not closing a chapter; we are elevating it. As humanova®, we embrace the purpose of improving the health of the future we aspire to,” stated Gonzalez Jover.

The event concluded with a message of gratitude to partners and collaborators, emphasizing that the future is not something to be awaited, but something to be built through innovation and conviction.